ClearPoint Neuro, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $45.9M | $20.1M | $23.1M | $27.6M | $54.1M | $20.1M | $5.7M | $3.1M |
| Accounts Receivable | $6.5M | $4.7M | $3.2M | $2.7M | $2.3M | $1.9M | $1.1M | $1.2M |
| Inventory | $8.4M | $6.9M | $7.9M | $9.3M | $4.9M | $3.2M | $3.2M | $2.1M |
| Total Current Assets | $63.6M | $33.4M | $36.2M | $51.2M | $61.9M | $25.5M | $10.4M | $6.7M |
| Property, Plant & Equipment | $2.6M | $2.0M | $1.4M | $806.0K | $539.0K | $319.0K | $447.0K | $377.7K |
| Goodwill | $7.5M | $0 | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | $13.9M | $0 | — | — | — | — | — | — |
| Total Assets | $97.7M | $39.2M | $42.7M | $55.5M | $65.6M | $29.5M | $11.9M | $7.9M |
| Liabilities | ||||||||
| Accounts Payable | $1.3M | $1.3M | $393.0K | $272.0K | $427.0K | $300.0K | $966.0K | $500.9K |
| Total Current Liabilities | $10.8M | $10.4M | $7.4M | $6.8M | $4.8M | $3.2M | $3.8M | $1.9M |
| Long-Term Debt | $49.1M | — | $9.9M | $9.9M | $9.8M | $21.3M | $2.1M | $3.5M |
| Total Liabilities | $69.7M | $13.8M | $21.5M | $18.6M | $16.8M | $27.1M | $7.3M | $6.3M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-216.9M | $-191.4M | $-172.5M | $-150.4M | $-133.9M | $-119.5M | $-112.7M | $-107.2M |
| Total Stockholders' Equity | $28.0M | $25.4M | $21.2M | $36.9M | $48.8M | $2.4M | $4.6M | $1.5M |